0% found this document useful (0 votes)
34 views48 pages

Pharmacology Logbook - Jemo-1

The document outlines the essential knowledge and skills required in clinical pharmacy, focusing on various dosage forms and drug delivery devices. It includes comparisons between generic and branded medicines, detailed steps for administering different dosage forms, and guidelines for setting up intravenous infusions and blood transfusions. Additionally, it covers the preparation and use of Oral Rehydration Solutions (ORS), including its composition and methods of administration.

Uploaded by

barmananubhab00
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
0% found this document useful (0 votes)
34 views48 pages

Pharmacology Logbook - Jemo-1

The document outlines the essential knowledge and skills required in clinical pharmacy, focusing on various dosage forms and drug delivery devices. It includes comparisons between generic and branded medicines, detailed steps for administering different dosage forms, and guidelines for setting up intravenous infusions and blood transfusions. Additionally, it covers the preparation and use of Oral Rehydration Solutions (ORS), including its composition and methods of administration.

Uploaded by

barmananubhab00
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF or read online on Scribd
You are on page 1/ 48
ae all Pharmacology logbook Pago 6 Section 1. Clinical Pharmacy A. Dosage forms and drug delivery devices By the end of this module the student must have acquired knowiedge and skills pertaining to: Medicine label. Generic versus branded medicines, Enumerating the diversity of dosage froms and drug delivery devices. Use of oral solid dosage forms. Use of oral liquid dosage forms Use of inhalation drug delivery. Use of injections, infusions and implants. Use of topical dosage forms. Setting up IV infusion. Setting up blood transfusion, ‘Administration of oxygen Carefully remove the label from an expired medicine pack / container of a prescription only medicine in India and stick it here. Note the various elements in the medicine label 3x sma Dosage Foren & Totals Sitagliptin50mg& | |. Gener Name & 7 H | Active. ingredients: Dapagliflozin 5 mg Tablets i sel Lene Sitapride-Day =, Dosage Strevg tt. Serre 50/9 I—> Manufacturers Name. Compare and contrast Generic versus Branded medicines Branded medicine Generic medicine "Medications comtaiuing same ae *Medieatint sotd undes a trackamaal| ingredient as bron. medicine bub) nome ley A plasmatetical com Jeol under clanteat/non-orendek — Hat cievihopeli fecenr ro"y Je They ARS much cleapey. o They arc expensive. ~ le Broven to le (ofoequivalint to lavemdle Con Sfoleaect as Stenctadd wsten | Seas first infrecducedt. Geuerte Ares rmall a rato tte ¢ hemctaad + flocks Att fevenr di“ Fadtraak *Oulgu appeanwrnce Gy yer laos. A 6 |, |ichanty. Also approved after bockies Fete Ie en er extance CUR Skat dotl « pharmacology logbook Page7 Enumerate the diversity of dosage forms and drug delivery devices here. = pee ere *Semi- Soli Desegt, forms * Do forms 2- TeOtutwunt, Creamy Geds one Dosage i Pactes, Uniucouts « Trramsclermas drug te Uvery System . Clowable Tats Enteric Coated TH Te : ae ty. Extendect Release SooMtS” |e SupposMonies » Smplomts- ae Doyy Delivery Devices o— vile S ing uel tatolete, J Spingee & Nbeckies vilir Mould act +etolers ix. Pettots. X+ Powders. ie Snfus Por pumps iis Auto-tafec ters ( theutn ens) fue Sntratlers (MOI, Kotatater) ib: Loaenges or Troclus. Ve NeloutPoers . * Liquict Dosage hoevag 4 — [vt Smplrrtable chevfers . Snjectins. ee Vile Tromedsmal patebet- eit drops /Nasad < prays eae val al any cletivery *+ Uipesomal of Arlive sytem “Ef "7 Draw schematic diagram of a transdermal therapeutic system (transdermal patch) 7 > Prlietive Fen | Brug Conteh "A Recorton. Cl 3 5 Ralf Controtbitg Memls oe 2h qs havin pervect tLe Ga + te a ™ Adbeste layer 6 > — we OS Bier “a 2 Tharapeuki Ske layer (Cfeculation) fy Toren Trerepeutte % lay Pharmacology logbook Page & Note down the steps in use of the following dosage forms Metered dose inhaler stake +60 Prhaleato uix the meclPeaton pr eA « ° Remove +Ge P *Kensnge et wdle Hho ta p)Ptie he Prlales lay Wotds ol TE sprny Tle cab ae. est ie + & Gobate lank. aA ory your © PLleethn mouthePeoeF yo uy ece tn | Fegey sana Rectal postage @ Snake te wredPoation ethene, ‘ Stomuttpmcously bg presing Ge eHold Your Breath by IOeca. ° Boldt Sloot iu a ° Keploce +H.” Cop & Rfrse Youa Moute- Rotahaler Conhpaarment, *Stomd or Sft wT Ups. © Cham +2 2D: e Open tie wotahalia = oTneeat tGe medical x Capeule Pn tho Ane * Cloge 462 votalialey lo: Preeshy the tse halves & Fere eo Stond ov SF desig to Open UD adr nay se pOsclaie cue Core Bs > Place tex mouk pred € 1) [yous rout Ba Het OT soo le On lrake. the gnedicadtion deeply &aqut “Hols ah oped +6, for tO see B etemhale slowly: wal cloth or actissuz paper & Rinse Your mouth + worth Subcutaneous injection eSeloct thi2area (upper asm, , Aoclomen )to be tjectad| fess Oe oa potent préferen © Use the sterile dry prepavatig meomt for sula-cutam ests injections eUse a shost tO ueddle, © Tibcten toes k Pry hold #2 c pig! Cieza pencfl B insert. the needle at meas slfn- fold at om ong 20-30° 2 Dutt toack 4a plunger gentty » iFuo blood pass in thw sy infect Vea cry Stee: Jp OTA awd neoctle quoter & press sterile susale Tato tee opentig Br Fx uit adtasive ee * Cheon » Afspore sfisasle Sofelt & wetk pomds. Intramuscular Injection glovese muscles ot Je StEdrows ws For shaap vo * Th case amy blo: Side eflecks. ePerform hand Wjafene & vwoear Oneover the area +o loe fafecliel e Clean the sfte ushisg Atco! chavactertees & uncover: Cf cust tater ef * Allon the site tock © Punt of the cay eTeu the atten to velar the e Insert the needle soi fry atan| te Go*, . 7 le Sryect sloust CoS - 2 nid) eDrgcard the s priage Fr abettofn We a day sFeatle Fece = Soa egies Sect : erat ate patient fr Y a re motion eae Pein ttre needle. te aoe od oozes, Pat nen °Uf Gleed oozes outs Fed Ate ance eee ate Aon fe Eres pentans Eye drop/ ointment Ear drop ane et coe eyed j poe < Le) te J-ro0am te ear Arops loy keepr ottex acute) 2 Was your lemd$ «beau tn -tCue orn SO eb conn ll ‘oe coun ot Fn eee nae a P ° +02 patieut—to (Sale & fie -+ec2. DUS Fe ecebstte rashes eStats fie Teh teas, beed oteromal or Ue exiucg ten Aro per cloce-to ttusye [it Gently Pull the loloe ~to erpese [= Bly eee prbsesPoeet amount &f-| Ce eat pelo epteleQrtnt, dase cess |, Sete Ge ammount Sf ers at “ease . cided + Armed) + Lek tee atts We [ys LoaSt foe min wefore faci ack pot aah +0 the Of062A BAR. «TEs eve should becletellyt. Vee cotlen Loost 10 closotEg Pharmacology logbook Page Note down the steps In uso of tho following dosago forms Intravenous Injection, le Perla homd by gens fh wocaa loves le Uncave x ~ICvo 1A completely lersk-IC.e parte -tovelax & 4 e HOe a8 ‘loclor +C.e yetn-te be Apply -rournsq uch Br look-fora port used suitable vei, * Vint For tex vetnnlo swett. P Clean tre aile usivgy alee rot SOEs B) ALLOrS +CLe wart chy. Jo Putt one we PS oe CTC eR inte rea cones es fe Keep fis heat shrots Py Eye Ofubuent ane oppltest ti jSarmre woo as ere reps. ean Canad ee era LL Pharmacology logbook Note down the steps In use of the following dosage forms Page 10 Nasal drop © Blow the nose. © Si don Bet lb hoadk backwar 6 a Of chops precenloedl + Smmectfatety afinnaact fl Hho head \Jerm fe re Bed ta between +e ky °SPt afles a fev seoonds| ee ede Ht dniptotGe Mariynoes ° Kineetie coo; ‘io ost tG bof lect roolEa 02 @ Inserttée dropper leno Fate | Lefe Biche POSPtee Kenee briget) He Uoshil & a +e amoutl| bent -towwaads ates Pep re tte enomalk?t: erode tasjoua bende ° fe cetfent on +CaP ir ° Lularioati Eve. now ZB Pnseat the eremea -Hy fato He veotur alsoud 2-Sinokes Pn adults » less -frr ett ld ren: PAdutafeter 4he , solution, beg fal SIO serersivg Hee wecturm oie ° orn the ene tna? a. Keiatn ta & teen roten tie urge Ps chong» Use fae latersom —to expet the BULUAR eomtentss © WALh your tromdt: | © Mortfter the effects Eivelre f fir con statis Rectal suppository 2 Wash tha bends 2 Luboefeatt the ends witG A “9ahig- soluble (worteamt o Put ongtoves ° Snsext -+tG2 s into the rectum tn of toe # the upp wp alea ETT yn ot: upto eel sot he “noaga-the lomds. Vaginal suppository © Wash the Komds © Prepare tes = pottery ° Get tnto a cortintatatl position Uke Fn Uttotomy posttor posPtim. © Snseat tee supp my qenry into 402 © Le atoum for a fer minutes. © Wash your hemds. Pharmacology logbook Pago 11 Note down the steps and precautions in setting up Intravenous Infusion DA mG oe te uot & 2a SF nook [Droctebiieg For | for Gaclcf af eaaes pump to conbrot FIs rate By mrroud dey th ad l + Blood transfusion one ® |i) 1) Pesferm Land iH Desiam Sm poset Phan aR. water oe. fnelu “ef D Gather Supplies Dpicoot lor papa % Crroosh sutigioavern& amen mee eetunad Claas +O SPU oshtG, andi. | Correct ea By motels soph ripe & terete Pobenty ae tood +a pe- IDAu Tv Gus Pe Poort Tato averus us +E orm oy ‘DTine blood) rensfucion once P ie 120 wA [bor ouce bl & seen rewore | DT, patient i¢ clocel th useclle Gr cores] Dt pai tor 2 BD Privates Th toh +o et a tremsfusion red ck Temove afr lbutolo! & “fo inst ak [Sndn, ee bag on pole orally 35 as paren P Shodote eae Free Fe Pees pomatusion role cam bbe zs CHR tes ie T/v Vitel of cole Dennett ine ah viel een tit QIV nes arzrvemovect roms: Assesewe xf patiots ornate 2d [rain or fae storot ot ST heals 160 en LE Nz. Fill-up the following table on oxygen delivery devices used in your hospital maT ‘Other notable features ose of, davon axinum fowate—[F, musatcannunipronge [| 1- © L/rnty _[25-4Spfe? OS USE EE or Oreo” Face mask (simple) G-S L/min |4O-6oP+ ISvould nok be used corte | Ventur mask 4-8 L/min | 2u-407 eee: Ae Se ceagt = 10 = 1S L/min [10-1007 ite etl = GO L)min [I-07 [Serre aR oot cid uppv ewes. 8 | 1¢— 720L/rmin.| | DOF: ReeeCH nena eno as mamma, [20-600/-~.] 1007. feiuts uae eireaey NRBM = Non/rebreather mask / HENC = High flow nasal cannula / NIPPV = Non-invasive positive pressure vesiavon BAP = Bievel positve airway pressure / CPAP = Continuous positive airway pressure Teacher's signature upon section completion Pharmacology logbook Page 12 Section 1. Clinical Pharmacy B, Preparation and use of Oral Rehydration solution (ORS) ‘ho end of this modulo the student must have acquired knowlodge and skills porta cy ‘c _ Rationalo for oral rehydration therapy. ane + Composition of ORS with its osmoiality J Reduced osmolarity ORS. «Method of preparation using ready-made ORS powder. © Correct administration of ORS. «Assessment of dehydration and rehydration. Write down the composition of World Health Organization (WHO) recommended ORS. Sriinal formula Tovised formula (Reduced osmolarity ORS) Component Amount per Liter] Corapouent Amount/t @) ——W | Nact — 26 Nac _ a.co | Tetspctfium CPhralz— 2+ detuycdrate Tei soduws lee Pai ydeatl — ae Ket ——— Ka Glucose (rnlyyjavous) — ao [2A a GS mmot et rer Gemma I terns Kt 20 wol/L . Stow > BOmmstle egmeteity Tote Osmolost?-+ty= 3 ~ Vs eNat —— Fommot/L © CPhakk— —1omol/L 2 Glucose —> AEmmet/L * Totat ep Glucose > ttimmstic 31min 24S A Oomn/L- Mention the purpose of each component of ORS. Component a Brom. [rete tae Mane este camer Glucose pag ee th vooder alosorpifon via sockFu mm glucose, Porasstum Ciilovicle. © Gta Prices quick sousce sf 2: ye SRopinces poiaesium loss fy Uarstaa. aie eChlowmale Lelps Mamntaty elecbolyle lbalomer+ [SokFarn Ri-castonat| Act, as a buffer +o correct Metabote access * Corrects acid-base Pmbatemce+ Ta¥sockfum clrate 7 CFs is more Stab & effective them Sicaavo- hale En ORS pharmacology logbook Page 13 Clinical assessment of dehydration and rehydration in childron ~ list the sallont points. Changos notod in dehydration when it is Clinical characteristic Mild to Moderato Sovore Geucral Appcaromce|Trattabley Alerts Thiasty. letCang ic untonfront T Capi lary FPLUisg Slightly Letayed Delayed Pelee, Rapral » Lexo volume weale & + Cyreody Respiration Nowmat to Prcveased nerenseat Prreled Slr _| Bove F ay no temting laumcce oe : Eyes KMormal to sunken oe Urine Output | Noemea to Reet meena renerally to be repeated every 4 hours. Note : Assessment s 9 Write down pointwise the method of preparation of ORS (using readymade ORS powder), appropriate use in children and the counselling that needs to be done for the caregiver. Goumst ug #— [Frepasatiom of ORS 2- ous Gor! & coet one Utre sfwala| eile maa betieg oreget Beto contuue Sreask a. » Open ORE sachet B act +e esfalild wot breast feds {iole content fo oe Irae la gid vation oa ee ee cree Set ew [Eup rece oeeelonss Ps ready Ue & r develop, Stop ORS ® eons “ebputd be Usredl within 24 | plain water or breashkmrlic hours: \ HU PUtFess Afsappeass - _Appropriadz use tn childrev, of 402 ctf ld vourtss re] CO for 10 ER MINS & thon Dat tslusect-fo prevenk er overci ftuid Coss as | slowly staat ORS- cenyaration dete Bake cinch arngumiet ok6 Fu *Solutin prepared to los Re Bae evtsy episode of Bie reer |e ca aie ec EEE a Spouse t— Puatd den <2yrz —3 SD-l00u4 of one «Children aebyes 7 loo- 200m 5 + Children > to yrs 7 200-260 Sf ORI. Teacher's signature ‘upon section completion Pharmacology Page 14 Section 1. Clinical Pharmacy C. Pharmaceutical calculations By the end of this module the student must have acquired knowledge and skills pertaining to ® Weights and measures used in compounding and dispensing activity. ® Concentration and dilution of liquids and topical medicarments. ® Stock solutions. ‘* Dose calculations involving body weight. # Dose calculations involving body surface area. © Dose calculations involving parts and proportions. © Dose calculations involving reconstitution of dry powders. Dose calculations involving parts and proportions. «Dose calculations involving reconstruction of dry powders. «Dose calculations involving flow rate IV preparations. Weights and measures used in compounding and dispensing activity Based on discussions held in class fil-up the following tables Metric ‘Symbol Multiples of base unit Mass example Volume example system prefix mass/vo lume li) Plo kK V/ 10 Taree le?loli tre —4 / —! 2, ° 2 10 crarany Plitbre D veel a 10 be 4 Dec? i > Con? a Lo S/o? Coutipram Cont? Pre aur om Lotfi 2 REM greme EUR 5) Mir Mh oft of MPe neem, [ttereU re Units from other systems Metric system ‘Common household Metric system Used in compounding and equivalents measures equivalents dispensing acti iy Avotrdupers Syslin D I Teaspoon fit Sm Ipound —> O°ASKA | |) 5 Le csert spoonful low] Jy Trey Sys lin lounce —> O ene DGattem Systin lgatirn — = 3H: Di Talotes peor Fatt tg] 1 dreP 0-0Sml pharmacology centration of liquids and topical medicaments Page 15 Concentration rene in cas itp the ain en Method of ‘expressing Meaning Examples concentration Weight per unit volume Amount of mass present 1 untd volume Tre cleustty. Adult Hb Concentraken ——_ 13-14 rg lau Weight per given volume Amount Of mass present IH a given volume Pruenytoin aval ble as 260rmyq/Sr\ Conc: Percentage Concentration wiv Amount of solute per 'Boml ext Sotn- SY. Aantrose (Byrn toord| Percentage ‘concentration viv Volume of Solute per [00m of soluton Fro mP of alocolute aleottol in loOml ot Pts aqueous “solukmns Percentage ‘concentration ww Amount of solute fa gqrams Per looml of solution: Benzorc acfol 127. Gy ) Ratio of parts Relation bir entrees work thie Companahive a ay 100,000 Epineplainelin} D Dosing of tropical medicaments. Based on discussions held in class fl-up the following tables Region to be ‘Approximate amount of topical | amount in terms of finger tip unit (FTU) covered medication required* (in 4 Face and neck fae re and beet) es 13-s7 ‘One arm .t Qs ‘One hand o-G aes ‘One leg 2-4 ae One foot oF Ae Whole body 20 40° * Single Ight application in adult person Meaning of FTU gre Riawneter em denctivg [fore finges +o ventral as amount GF Statmmenbh, ream or SeumPsolik Lesage Horen 2 bruced Prom a tse notte a uoorte of trem is teterease cg pect St -—fuces-Hp- whose dose may be expressed in FTU Examples of medicines a ctepfeal atersidc. clrocorticonsy Betawetilncone & 0 \ pharmacology logbook Page 16 Explain the meaning of the following in relation to stock solutions with suitable examples rc Stock solution St ts a lagge volume Sf Comman reagent Oto slomdbacise’ conamtration t Qa” AM of HCL preparech from 16M Hel Stocte+ ; The procese of acing mere solvent ty Dilution a solute Ps cated ' L?lution- MM, Snitat molaiky MV) =MoV9 Mg Final revo tae ey Vj Pritial Volume vg— Ainat Volume - To caleulale prporifons of ony too Solukoms to ac wi¥xet to prTepere Lenat solution of destrec concenhaten. Dilution equations Alligation Dose calculations based on body weight and body surface area. Note down examples discussed in class. QA child's wey Fe l6poundc. Adutt hose Ps loogy/d yea ropabele close re the child, a — By claak’s Formutas q| doce in eluld = LOCO Adult dose. Igo = [00x _ 10:67 Boa. so Qi) The etald hac becky suaface ance Ff 0: G7tm> ye ie a etl » Pind dose =Porterctild. — Dow Pr cldld = AckuIt bose * Body eushace A220 Adutt looky eux face Ai2a- =_©7F » 0-67 Tx = 264g ]4e1* pharmacology logbook Pago 17 Antu ent (drops = Dose calculations related to Infusion remember the following Infusion equations given alongside: Flo ate (nt 1)» ote down examples discussed in class ‘yA patent &s to vecfeve IL af Reuger Laciose Zoietfor over the wesc (2 bre: Dereantve 104 tufusion rales ff traa drop tor ?. hon rat placer Ps 60 dept _ + Snfusion reali = Volume x Drop-factnr Hurection ~-[ infucen = 10 COX6O _ £333 12” 60 Q2) Snfusin 5 (voomL we" clerctroee trvcnnet “eobur 1S to be given oves Cuouss- Coreutale < tlre -ft akin H OAso THE dvie vets ff ayop factor Ps Sqft: — FI valz = Volumt = loOO ~ wad [bh , we Dweto S a Drip walt = Vol x Davp-factyr Time = 1900x ISL 2 dropyfn? an. GO X —— id Teacher's signature ‘upon section completion | logbook Pharmacology 10a} Pago 18 Section 2. Clinical Pharmacology A. Prescribing and prescription review By the end ofthis module the student must have acquired knowlodgo and skis pertaining to = Meaning of prescription, the ideal prescription format, common accoptable abbreviations. Do's and don'ts in prescription writing. Legal issues in relation to prescribing e.g. prescription of narcotics and other controlled drugs, banned drugs. prescribed for sportsperson. Prescribing for commonly encountered clinical situations. ion and prescription audit. Prescription review, prescription reconci Define the term prescription A presemipttian fs A vortten orden Gy a loctor Fo a pharmacist to Aispense the gtatet medPePues ov ee therapeutic ts Pu +e ape ci fret stremgt&s closage foam & Qucmttigy te a pasdPeular PoctFeat . del prescription in the space below and identity its parts Write down a simple mor Dr. ABC ase MBBS g Regis trocimnd 384 4 x Address panne Centact: no - Ages Sen? Address * ley ho eB & Tals Let Aatterromy chu S00 “4 Gat ef Dispense Such Staite “7 (each eon talahng sore) dteit +o be taken 4 hour befere meal ws once daily for © days. o ABC 3 Dati Reatsiation Trumioes. logbook Pharmacology lo} Pao Note down some common abbreviations used In proscription with tholr moaning [Ropevation | Meaning Foweviation | Wenning Tord [es B-@ | Diccontuu tid Htrtce datly x lice s [ aid [four tine s a deny Yo Nease olel Ac before meats! om morris Pe After meats pro | aft. noch. IV Sn bavenous ly TM _| On rramuse thi Subbt Subeutaneoust ss ome Lalf I wdater State what are controlled drugs (in Indian context) and provide some examples A contiotedt drug Psa chug or Otter subselance tose marnufacire » possessions sate Er use are Halt | controllid & rvesteretet by tHe ovean ments bedeuse PL may be abused or cause ack dictfen . a4 Mov plPuc Cocke Puc) Amplrets aoe State what are banned drugs (in Indian context) and provide some examples of recently banned drugs with reasons for banning Banned dregs BAe TAOSt (Ste AGE PROLILIER for mauufactue! & sale by Ate government because of rds effects trel last ol varticatte -fotet. pst reasms &— 4 St causes upper GL aed I Caahine C fea pve DROP aor artiyeuntal Sy heater: © Practo lol 4 St causes Octo mucocetancous syndromes @ Auatain > Bone Margoro depression. @ Nine sul Pele — Gauses hepatfe feP lune - Pharmacology logbook By the end Section 2. Clinical Pharmacology B, Adverse drug reactions and drug interactions of this module the student must have acquired knowledge and skills pertaining to Meaning of adverse drug reactions (ADRs) and its implication in pharmacotherapy, Different types of ADRs with examples. including serious ADRs, Pregnancy risk stratification of drugs. Meaning of the term pharmacovigilance and various pharmacovigilance strategies ities of the pharmacovigilance program of India (PvPI). Objectives, structure and acti Brief overview of other nation program, Adverse effects following Immunization (AEF!) progral (MPI). Spontaneous reporting of ADRs. Page 26 nal adverse event monitoring programs e.g. Herbal pharmacovigilance im, Hemovigilance program of India © Basics of causality assessment. Meaning of drug-drug interactions and its implications for pharmacotherapy. © Different types of DDIs with examples. «Examples of DDI involving modern drugs and herbal medicines. © Examples of drug-alcohol, drug-smoking, and drug-food interactions. Situations that increase risk of ADRs 1 DDIs like polypharmacy, high alert medication (HAM) and sound alike-look alike (SALA) medication. Define the terms Adverse Drug Reaction and Drug-drug interaction ADR Avg response Tattels Te Vrortoudy Umintencted B eleeceuas at closes nermatty usedtn lumens for por pry axis s dfagnon's Hoare py of dfscasey ov -for modifeatton of plry ciolesy ic =fuaction: DDI Pacthe meahawitmn of acho ofa drugs, vresut Huq PA an array oft ae 3 dma toy Tee concomitant ad uPure trot on oft suSktemtes Such aS food » lbeverges ov otter sie eF fects List examples of Type AADRs ror lad, |wetatid +o Pt praamace tox Gang VLR of wouter, bierney [DSrcke effects} Atropine produces any Uw vel B)Seconelansy |. Corticoctersidt couece Predictable reacttons to at call actions. wos)» beantion. Ronen anette ef wWsion, lead to © ppustunistic Pnfections lk 2 Tooctc |, Bleecti Austs Ovesducas wt ante oa, effects [Uke rSla-fartn, Neptre torte, ratte, av aty. IF Petre ORE rression nStG fe ovat Cometic geben of Le awit jiate Pharmacology logbook Page 27 ‘Type BADRs Pearre (ora RE eti0n3 Nom tose velalécl wv npr eclic table Yeacttane Ho Aodlruqg etPelt ane uot velatid +0 Co] prasmecG| leg?cat actin. Rasy Briteth due +e exposure -bo peutes Uru. Derg pee) tence tt einen prodlicedl by quinictive Phrihs wits AlSaAlD ¢. Contact de ooh dermatitis due 40 localornosilu tye ¢- D)Sckte rey — Aplastic au * DY eproy Pare queue caused Oy # Xlorervnplir tue ct: ‘ : is. — Hemolytic aucuia seen where Gedous ADRS Potential) Ufe thrreatitays Cause ¢ Rrrerne. F Jatamase or requtre Clintensive mecticat treatGhont - D DrqosePu—F Veu brPeutas bac bry cork LD DOS teeta es & Cmca D borbi Salis — Respiratory cLepressionts Pharmaceutical DDIs| “The PuteractHons Occur laefore A russ one actualy wtinPsterect to tie palbert & repre su incom pan bi i a D Hepaam + Te hr ey tine SnaeHrabian st jd) Antares + Sucrat-fale —> Vices proGetve e Feel Deaton Feha + Gatiamine 7 Musehe re laxemt ettect ic inevreaset D wastertn + Gingko bilo ba—s Onereasedt Herb-drug Interactions blee tic . 2) Calor propandicde + Alum Gobrvwm qd —"_typegiyernein Food-drug D) Mao Phe? bors + Cleese > Maliguank hw P ry tension. Dd qeaew ot Antieoagulants — Snereasech of suctatfate is leet D plens teint Deschere —y forms fr selubtecalt & Prarmaconinete D GF Fam tt6Fasid et, hx Aecrenieet tr | |2)Kifewupfeks roc Pe fetuses Tf co teacspbens, Dliproftoxacin + Treoply wine — Palpitations ; Convules Pharmacodyramle D Eaata pei [+ SP frone lactme Re anes / _ bleeot’ ‘4 Pharmacology logbook Pago 28 Note down foatures of tho following casuality assessment scalo World Health Organization-Uppsala Monitoring Center casuallty categories with featuros genes tedeie The SHO“ OME Sys Ps Cambincd a atte tiie $= Phasmac ole: cal aspects wy anol phe aoc fl of oloc umentateh, Rute account of the case vo dausatity {erm Asseasnent Corl _ eEveut oY Calcorators tect Ub nov ma UE Cevtatu plausible Hace re tim stup be olruy intake. O warn eGamot be ercplarucel by Cereea sa oO Ottor aoe s bu. £3 pharmacelag? catty = — © Event ov LAbovatory fest abibormalli ty Goransal plauw @fessibvle Ne peconatcle Hurelrelaione® p to dai ~ intatre « . q eCould also be ercpltned Ce cUiseaces oy Ones kvept : eo Snformsitfon on trug votttictrawal mea ee toe lacteivsy + q Y @ Prbvatte / Event ov Cabboratony desk Aner matitey Wet WH Yeasona ble W-Hmae welatiom sp A +0 clvug intaie+ > C Ont éade “to toe. atl Mbuled +o decease & ofuay a clay + ebvenk or een FESE COB ALY esis a tue +o clu, Putalke, e Disease ar otter d << provide plow lceneckaay mgs P e @ unekety Wwwns ae @ cond? Honal [+ Event or Cats test aburnanty ~ > |e Mowe data for proper asses rent neececl © vnc tase*Fatte.|” Report suaaes Rey on AavreR ge oT RAL AL | Data comnot tae supple wenlict er verilie| List examples of High alert Tntravenous Leparing Oneutiny DY potassiwm, medication in the narcotesr . ITU setting Sound-alike look- Deukei ne a Bopaws “ alike medication that | AAr-erra_line , Albeo pire you have come 5 a Morphine, Peter cline Pharmacology logbook Page 29, Exercises on case sc enario based filling up suspected ADR reporting form Scenario 1 Mr. Prakash Jadav, a SSyear old man weighiug alour cous came to Medical Colleges Kolkata on 25/68/2020 astttt fevers CLI US 5 pafn ful slam rashes » swelling of Ups: On exanduation, tender, purple voide react prastes on Ls loacks cect, upper abdomen were noticed. +t7s. Tevealedh 4eat Ke had an attack éF| muppets Pnfaactfon TA +e recent past. tte stdated talcPus Tab. ASPIRIN Sma at nigts treodays| back & cdevdtopet tte eyrmproshs on 24+ 06-202 He was advi +o Stop tte of Pramechiately Ga was presczilbed tab: Predurcoloua. ACter Bolays he recoverect+ FFL, ADS fos: Scenario 2 Mr. Neranlar Mo: pe man oF AS 4/0 > e4, esky loame +o tee OPP af Medical Co @ on Ol+ ce?2020 Lotte, qeneralicect body ache » Pictifug Bskin yacues. He gave the Lis ot trtone of Aor FUR for ttreahwenk oF Resp: Tract: snfectionss lon prevfous doy] lm +2 symptoms appearect immediately afrer taufusieg Hrug- On exaninatfon tere rere Ps puss SUA Tastes ON lott. asms ,foreosams Ba -Ffromt sttte| eben. The aX woas stopped ee eaeegenee || Sha wag treated He ante La stand wes. SAFtes Adays le recovered. Fru up the ADR -form- Scenario 3 Mrs- Kunt? Dew’, aSSyrold lady woetg et Se “a> octey Hee OPP oETISMSER, rsofi nausea Bish eprsode: hamatemesie & modenalt epigastric pata omnia: 2 vstPeh Kas occured afunce Last 3 Lovys CA/2/21) + The poas Lo futake of Tabs Ibuprofen A0omsg Drstee dasl} sfrce Lact Qmenth<. Endoscopic exaniuation reveals erosion Pu Lower eetestesataan mucesel Yegion: She was advised Yo Manediately step ite Ars « He woas tremtent vohte Tt: Robey rancte 20 Htostee AM Ply closfings After Golays <4e4 relieved Tera eee ADL fore, Oe Spemplersget ‘Scenario 4 7 Raesk Gan, 4% y/O; male phy roapeing aloouk Te re areas Sto ed silence bn noe koosd doh te JSwollan Ups tHe gave tee Lister, of talek Ts Rawstp: basn 08 after ‘oreanfach the +e at it SE} vyperthacton om the Lact day rotich was frst staateds “The symptoms arcsec last nh + He das fastructed to 'Rumudfately stop tte tolrug. Te Levecetrratre (0 Ob al us voas arSlen » He became symptom freed from 21-G.2020- FEA up ae AO “ esopragest Buppes gashig nck Pharmacology logbook Pago 30 SUSPECED ADVERSE DRUG REAC er i i i ete Sree Reg. No, APD No. OPD No. CR No, "AMG Report No. Worldwide Uniaue No. 5, Event/ Reaction start dato (ddimmiyyyy) 2 4 J, S Event /Reaclion stop date (ddimmiyyyy) 2 B/ 6 6_(A) Onset Lag Time Adays. cacribe Event Reaction with treatmbnt detalls, ran) mreserdtedt Wott fever, clubs] astrewe : 2 ecgrancy bseltven ee Ups Pa neat sin rashes. NA ge, tender, Purp UE pstdespreadk A on tea! back, [ia seronmesToTn act. Dr seems ruati] em) Taboratory data with dates N/A Cleity Upper 4 [5 Death (daimmyyyy) 2 Congenitat-anatomy Sr of Asplhain’ By ak wl Tebra Hon OF [5 tie meatening 5 bisattty Talos PREBNISOLONE Ld-to TA 5 Hosplaiation/ Prolonged C) Other Medically imported 15, Outcomes I Recovered Recovering _ChNotrecovered vecovery of ta petrent + Fatal Recovered wih sequelae ) Unknown SE S-No]s.name __|Manutacturer| Baten | Exp. Dose Frequency] Ther seus (Grand’Generic)| (iknown) | No.! | Date (it | used (00,80 [Date Date] Indication | aSsessment tio known) te) | started _| stopped ASPIRE pratt on—leefeleo|zs/efeal MI —|Prebatde n i We 5. no] 8 Aalion Taken (Pease HR) To: Rewdion eappeaied air reitoaucton(pessech) 2 | ee Bun] inoSacea | mbuces | appicanie | Unknow} | Yer No | tectunknown | pose (reinoduced 7 o it We "f, Concomtant medical product Including seltmedication and herbal remedies with therapy dated (Exclude those used to treat reaction) fs.wo] Name (Breng/Generie) | Dose | Route | Frequency (OD, Therapy dated Tndlcaton tea | sed | Bo.) S aa started | _ Stopped 1 Preduatclems | — [oral = 2s 76726 Cont [Additional information Pie ae Pint fem ‘el. No. (with STD cos ‘Occupation Slonatur Doo 17, Date ofthis report damm) 147 S/202S~ Sig. and Name of Rec ‘Confidentiality The patient's Identity Is held in strict confidence and protected to the fullest extent. Submission of a report does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the reaction. Submission of anADR repor does not have any legal implication on the reporter. age for more information Pharmacology logbook Page 31 FORM SUSPECED ADVERSE DRUG REACTION REPORTID Fos VOULMTAIT ecertng df Karen Ory Paacten by Meaercare censors Worldwide Unique No, 5, Event | Reaction start date (ddimmiyyyy) LL] 2020 | %. Event / Reaction stop date (ddimmiyyyy) S/e o N/A 6. (A) Onset Lag Time Sdosys - | pexcribe Even Reaction with treatment details. any — 13, Relevant medical! medieation Raton (og. sTeraies Tone prescuied woites a oaralied [Pmgtrncy™ nome mowers onto Poet Cig sticling » stele rashes of 1, Cee, purplish skit rashes N/A. vaseds ol kA +AL 2075» fore- [= SS 3 anyone head, frompetctesh » Catfenl | |5\oemniaammnm) 2 Congenittanstomy recovered 4 days after Ascent 15 ute areatening 5 oistaey huaten of frspectedt frug & 5 Hosphatization / Prolonged Compuli adver tizement- Stato some of the ways that you may be misled through drug promotional literature ie ey false pletosto Pllus trations, .- 2° A use of voorads UPke “only pee ov “maar emecty 2 ral adverts. 3 Lack Ze onleguole lato. om adverse Aug rvovrolek od verttsors rreachons rat a6 Distortion » om, ede eurphasic, ouctesion or Pu ouny ottes se clisesip Hong such ay defer & eno et he oe ppeate” G+ NS Pater pretation of p ulo Ustrol lata 4+ Focused , matention gratiteg Dr banet dyiven over Hee wonts B+ Lack of person Knowledkee 3 pharmacology logboo! Page 36 tame some impartial sources of drug information — Sele? fre Tourxnale. 2 J) Po 2 Secondaay—> Snolec eatcles - Ar Promotional — fold Snternotonel Plas maemo e ar lerHooy —> Compendfa, test vooke ,revPeva internet, curate. mae, Mod Ure, Abstracts. ers» leave belt (eof. What do you think are the pros and cons of interacting with representatives of pharmaceutical sales personnel (medical representatives) ? Pros e Qntrocluces a nev produc Pr the market e SQnevreases prospeck e Sncareagea sales. oe campetitom. 0 Enhances geod wr tl of cement © Educalts +62 wo ket © EP Pralid niPdollemen e Sotesmam lu p supped. ° Raiqes stomdaadof Cons ° be inadag vote, Prvetilkd or mois endliy PLeads td miouopol TAX past q bremlA af proctuck- © Crealis agtPf rai ol dewaud sf +e product © Snerernges preter of ACR jorocluct. ° be tras ful for sou st eEnhomes art pation’ nrecdiceth 7 a Teacher's signature upon section completion pharmacology logbook Page 37 Section 2. Clinical Pharmacology D. Rational use of medicines d of this module the student must have ai py the en equired knowledge and skills pertainin, «Rational use of medicines (RUM) and its three pillars - essential medicines ln eon standard treatment guidelines (STG). ann aeen eee Framing of an EML for a given health ffacility / healthcare scenario, Sources of drug information. Extracting information from non-commercial and commercial formularies. Basic steps in promulgation of Standard Treatment Guidelines (STG), Steps in exercising the P-drug concept. List the drug promotional strategies which you can think of Rational use of medicines —» Accordit to WHO, ratoual use oF mediahes requires that S patents Cl pecieve meckieations appropral Ho teste OLPuPoot needs P closes teat meat +euir oon mrajority of +e pope quttity Javar Goat lati one Sheutd be ot ascured au tites 5 Py adequate quam+tHHe Hes &% Fu approprale roqmuaysPovenara] Pa a Comttuusdiy recieve compilation of phammacent” & Inelucli Tm porte + Pra Formation +Ga4 reflects +Ge cussert “ecrrcat Sadigenment of ta wiedfeal staff. ‘Standard treatment guidelines or protocols Stemdaad -Heatmauk, quiditines te Aofined At Systema te PLevetoped stalimenr desi +o assist practitfouer ES patents Pr note decisions abet apy WolE hKeatt care for specie CLintcal cireum wa S\A2Ht Grown eFatectolers TYE" mettiasone tablr/Snj- are n Omterrourbearote +atoler< gr! Wm aNHs 29 e Gace Veo sem Sin yee! 7 sme tutablet s)Albeucta s0te- ty DAapiafitamuts @ Poaacctanel pond oni + D levocetsfaPre tal ~tetolats + Bina tewnrmyeho rallar aS flte [aS ee gerrena sete toate. eoroFtomacts tales dant re Omeprazcte capsule + Dani Tod . Matoeial WHrogtycesty tab Let + “ys “ES | I Dlatvetelot tro let * ‘university class field trip into a tropical forest_| Emergency department crash cart [Loperanside tatolet. DSnJ- Adrenaliue 2DInj- Atropree| Dciproflerackn +etlet. Sn Bepanine ASnj: Noradrenet D poracetamet tablet )Snj- ACK OSPae. C\Bnf- Awfodare DAs Pata telat =) Levocetsiaine » Sri Furosemide DSi MS. Beuroregwine talk 7) Mabvoni-| DSM: Cattum Giueonate | @)Albendazols tates, Wazole.| 15 baloetotet 11) Sof Bigontn A oncklengetrem tebe 46S] ID) OT Lorasepam 13)Suj-tyd cor IDHomeprazroa fatoter Dn Uf peen 1D OEE. 1) Piclofenac fa Lar ID AritCre mye q ID)Srf De uttanntng. State some sources of drug information, including examples of formularies t Souacesi- Weu cotculatedt x. [DReicaay Souaces aD | randourd sect controlled DUnpubustsd stuctier, ° D origin Articles pubUshree fr reputed peer} revieloen fournats veportiigg omfg ital reseasch DSI RY SOS NEES Dgezen SOS Meio Uegreptical references, Abshact. D Tevtiany Sources 1— 4) Date bases) Tenctoootcs. ©) Re vous aatiete fn Pournalc Identify the kind of drug information that may be available from patient package inserts / patient information leaflets and drug formularies PPI PIL Formulary Yqenevia Kame Bi BYATE RAME. |i) Generia & Brandl Kame Stang Dlompositien. BD Trerapertic,, |Detfreacy- Ddosage B aduPufetration: A] satety profl of segs: B)Waanings & Precautions - ID Onteraction profile: >, Sick

You might also like